The object of acis Arzneimittel GmbH is the development and distribution of medicines, marketing authorizations and cosmetics as well as their licensing and consulting; retail sale of medicines is not part of its business. The company focuses on direct sales of patent-free pharmaceutical active ingredients and uses the central production, active ingredient procurement and logistics of its parent company mibe GmbH Arzneimittel. acis's product areas include analgesics, antirheumatics, antimycotics, osteoporosis agents, expectorants and dermatologicals. Sales are carried out exclusively via direct marketing without a field sales force; customers are primarily physicians and pharmacists, and acis participates selectively in tenders of statutory and private health insurers.
Entwicklung und Vertrieb von Arzneimitteln und von arzneimittelrechtlichen Zulassungen und von Kosmetika sowie von deren Lizensierung und Beratung anderer Unternehmen auf den vorgenannten Gebieten. Einzelhandel mit Arzneimitteln gehört jedoch nicht zum Gegenstand des Unternehmens.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) München Local Court, HRB 159656 (as of 29 August 2026)
| Date | Event Type | Event |
|---|---|---|
| 06.10.2009 | Registered Seat Change | Grünwald, Landkreis München |
| 06.10.2009 | Business Address Registered | Lil-Dagover-Ring 7, 82031 Grünwald |
| 06.10.2009 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 21.11.2005 | Share Capital Set | — | 25.000 € |
| Date | Contract | Value |
|---|---|---|
| 29.5.2026 | Supplier · DAK-Gesundheit | — |
Source: German Commercial Register (Handelsregister) München Local Court, HRB 159656 (as of 29 August 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2023 | €18,062,000 | €8,444,000 | €12,226,000 | — |
| 2022 | €15,769,000 | €6,659,000 | €18,898,000 | — |
| 2021 | €17,636,000 | €7,500,000 | €13,193,000 | — |
| 2020 | €16,066,000 | €6,423,807 | €12,523,198 | — |
| 2019 | €17,799,493 | €8,610,957 | €15,370,767 | — |
| 2018 | €13,893,068 | €5,590,768 | €10,957,883 | — |
| 2017 | €12,295,475 | €4,356,255 | €8,335,435 | — |
| 2009 | — | €832,887 | €1,788,133 | — |
| 2008 | — | €444,005 | €755,626 | — |
| 2007 | — | €45,256 | €280,418 | — |
Sign in to download data
Source: German Commercial Register (Handelsregister) München Local Court, HRB 159656 (as of 29 August 2026)
Premium Cosmetics GmbH
Eislingen · Großhandel mit kosmetischen Erzeugnissen und Körperpflegemitteln
Elizabeth Arden GmbH
Mainz · Großhandel mit kosmetischen Erzeugnissen und Körperpflegemitteln
IONTO Health & Beauty GmbH
Karlsruhe · Einzelhandel mit kosmetischen Erzeugnissen und Körperpflegemitteln
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €220,074 | 38.0% |
| Depreciation | €320,894 | 55.4% |
| Interest & Similar | €37,984 | 6.6% |
